{"gene":"AEBP2","run_date":"2026-06-09T22:02:42","timeline":{"discoveries":[{"year":1999,"finding":"AEBP2 is a zinc finger transcriptional repressor that binds to the AE-1 regulatory sequence in the aP2 gene promoter; the zinc finger motif plays a direct role in transcriptional repression (but not DNA binding), as mutation of a conserved histidine and flanking serine in the middle zinc finger abolished repression without affecting nuclear localization or DNA binding.","method":"Co-transfection reporter assay, Gal4-fusion repression assay, site-directed mutagenesis of zinc finger, recombinant protein DNA-binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro DNA binding assay plus mutagenesis plus functional reporter assay, single lab but multiple orthogonal methods","pmids":["10329662"],"is_preprint":false},{"year":2004,"finding":"AEBP2 is required for optimal (but not minimal) histone methyltransferase activity of the EED-EZH2-SUZ12 PRC2 complex; the minimum active complex requires EZH2, EED, and SUZ12, while AEBP2 enhances enzymatic activity above this baseline.","method":"In vitro histone methyltransferase (HMTase) reconstitution assay with defined subunit combinations","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution with defined subunit combinations, replicated in multiple subsequent studies","pmids":["15225548"],"is_preprint":false},{"year":2009,"finding":"AEBP2 is an evolutionarily conserved zinc finger protein that binds DNA via a bipartite motif (CTT(N)15-23cagGCC), exists as two developmental-stage-specific isoforms (adult 51 kDa and embryo 32 kDa), and co-occupies genomic loci with SUZ12, functioning as a potential targeting factor for mammalian PRC2.","method":"DNA-binding assays, ChIP, promoter-GFP reporter, RT-PCR isoform characterization, Western blot","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and DNA binding assay in single lab, two orthogonal methods (DNA binding + ChIP co-occupancy)","pmids":["19293275"],"is_preprint":false},{"year":2011,"finding":"In developing mouse embryos, Aebp2 is expressed mainly in neural crest-derived cells; homozygous Aebp2 knockout is embryonic lethal, and heterozygotes display neural crest defects (enlarged colon, hypopigmentation). ChIP analyses showed that AEBP2 and PRC2 co-occupy promoters of genes involved in neural crest cell migration and development, and expression of these genes is altered in Aebp2 heterozygotes.","method":"Targeted mouse knockout, phenotypic analysis, ChIP, expression analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with defined phenotypic readout plus ChIP validation, single lab","pmids":["21949878"],"is_preprint":false},{"year":2012,"finding":"The first 3D electron microscopy structure of human PRC2 bound to cofactor AEBP2 revealed that AEBP2 stabilizes the complex and occupies a position suggesting an allosteric role in regulating gene silencing; cross-linking mass spectrometry and internal protein tagging localized all PRC2 subunits and mapped AEBP2 interactions within the assembly.","method":"Electron microscopy, cross-linking mass spectrometry, internal protein tagging","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure with cross-linking MS validation, single lab but multiple orthogonal structural methods","pmids":["23110252"],"is_preprint":false},{"year":2014,"finding":"Monoubiquitination of histone H2A by PRC1 (H2Aub) creates a binding site for Jarid2-Aebp2-containing PRC2, promoting H3K27 trimethylation on H2Aub nucleosomes; Jarid2, Aebp2, and H2Aub constitute a positive feedback loop establishing H3K27me3 chromatin domains.","method":"Biochemical binding assays, in vitro HMTase assay with H2Aub nucleosomes, mass spectrometry","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted biochemical assay with defined modified nucleosomes plus mechanistic follow-up, replicated by subsequent structural studies","pmids":["24837194"],"is_preprint":false},{"year":2014,"finding":"AEBP2 localizes specifically to PRC2 target loci including the inactive X chromosome; proteomic analysis confirmed AEBP2 associates exclusively with PRC2 complexes. In Aebp2 mutant ESCs, elevated H3K27 methylation at target loci was observed and atypical hybrid PRC2 subcomplexes assembled, suggesting AEBP2 normally defines mutually exclusive PRC2 subcomplex composition. Unexpectedly, homozygous Aebp2 mutant embryos display a Trithorax (anti-Polycomb) phenotype.","method":"Targeted mouse mutation, immunofluorescence/ChIP localization, quantitative proteomics (mass spectrometry), ChIP-seq H3K27me3 profiling","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal proteomic validation, ChIP-seq, and in vivo loss-of-function with multiple orthogonal methods in single lab","pmids":["27317809"],"is_preprint":false},{"year":2014,"finding":"The somatic (long, 52 kDa) isoform of AEBP2 acts as a transcriptional activator for Jarid2, Aebp2, and Snai2 target genes, whereas the embryonic (short, 32 kDa) isoform acts as a transcriptional repressor for Snai2; the somatic form also enhances cell migration. AEBP2 binds its own promoter and the promoters of Jarid2 and Snai2 as shown by ChIP.","method":"Reporter/transfection assays, ChIP, cell migration assay, RT-PCR isoform characterization","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional reporter assays plus cell migration readout, single lab","pmids":["25451679"],"is_preprint":false},{"year":2017,"finding":"The AEBP2 subunit of PRC2 regulates preferential binding of PRC2 to methylated DNA (CpG-rich sequences); inclusion of AEBP2 in the PRC2 complex mediates this specificity for methylated DNA.","method":"In vitro binding assays with reconstituted PRC2 ± AEBP2, methylated vs. unmethylated DNA substrates","journal":"Nature structural & molecular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — reconstituted biochemical binding assay with defined components, single lab","pmids":["29058709"],"is_preprint":false},{"year":2018,"finding":"Cryo-EM structures of human PRC2 with JARID2 and AEBP2 in basal and active states showed that AEBP2 interacts with the RBAP48 (RBBP4) subunit, mimicking an unmodified H3 tail. SUZ12 interacts with all other subunits; together these interactions define the complete architecture of the complex.","method":"Cryo-electron microscopy, cross-linking mass spectrometry","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution cryo-EM structures in multiple functional states, corroborated by cross-linking MS","pmids":["29348366"],"is_preprint":false},{"year":2018,"finding":"AEBP2 and PHF19 compete for binding to the non-canonical C2 domain of SUZ12; AEBP2 and JARID2 together enable nucleosome binding by the PRC2 complex. Crystal structures show that SUZ12 contains two structural platforms defining distinct PRC2 holo-complex classes. AEBP2 progressively blocks histone H3K4 binding to RBBP4 together with SUZ12.","method":"X-ray crystallography (crystal structures of heterotetrameric complexes), in vitro nucleosome binding assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures with biochemical validation, single lab","pmids":["29499137"],"is_preprint":false},{"year":2018,"finding":"AEBP2 stimulates both PRC2-EZH1 and PRC2-EZH2 methyltransferase activity through a mechanism that is independent of and additive to allosteric activation (by H3K27me3), distinguishing AEBP2-mediated stimulation from the allosteric pathway.","method":"In vitro HMTase assay with defined subunit combinations, allosteric activator competition assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with multiple subunit combinations identifying independent activation mechanisms, single lab","pmids":["29681498"],"is_preprint":false},{"year":2018,"finding":"AEBP2 and PCL homolog proteins make a major contribution to PRC2 chromatin binding in living human cells; SUZ12 separation-of-function mutants that cannot bind accessory proteins (including AEBP2) greatly reduce chromatin residence time of PRC2, as measured by single-particle tracking.","method":"CRISPR genome editing (HaloTag knock-in), single-particle tracking in live cells, SUZ12 separation-of-function mutants","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — endogenous tagging plus live-cell single-particle tracking plus separation-of-function mutants, single lab","pmids":["29891558"],"is_preprint":false},{"year":2018,"finding":"AEBP2 and JARID2 define the PRC2.2 subcomplex, which is mutually exclusive and antagonistic relative to the PRC2.1 subcomplex (containing PALI1/PCL proteins); the balance of PRC2.1 and PRC2.2 activities is required for appropriate regulation of polycomb target genes during differentiation.","method":"In vitro HMTase assay, co-immunoprecipitation, mouse genetic knockout, differentiation assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (biochemical, genetic, cellular), replicated by subsequent studies defining PRC2.1/PRC2.2 distinction","pmids":["29628311"],"is_preprint":false},{"year":2019,"finding":"AEBP2 contains a non-canonical phosphodegron and is targeted for ubiquitylation and proteasomal degradation by the SCF-β-TrCP E3 ubiquitin ligase complex; failure to degrade AEBP2 confers cisplatin resistance in ovarian cancer cells.","method":"Co-immunoprecipitation, ubiquitination assay, AEBP2 knockout cell lines, cisplatin sensitivity assay, phosphodegron mutagenesis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — co-IP and functional KO phenotype, single lab, moderate mechanistic follow-up","pmids":["31864706"],"is_preprint":false},{"year":2020,"finding":"AEBP2 binding to the C2 domain of SUZ12 disrupts the intrinsic PRC2 dimer (formed by domain swapping involving RBBP4 and the SUZ12 C2 domain), whereas MTF2/PHF19 stabilize the dimer; PRC2 dimerization enhances CpG island DNA binding, and loss of dimerization impairs H3K27me3 at developmental gene loci.","method":"X-ray crystallography, in vitro DNA binding assay, ChIP-seq in mouse ESCs","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures plus biochemical DNA binding plus in vivo ChIP validation, single lab","pmids":["31959557"],"is_preprint":false},{"year":2020,"finding":"PRC2 (five-subunit complex including AEBP2) bends DNA approximately 3-fold locally and mediates DNA looping via multiple PRC2 molecules binding cooperatively; AEBP2 regulates loop formation, in part by associating with the C2 domain of SUZ12 and blocking its DNA contact.","method":"Atomic force microscopy (single-molecule, in liquid), single-molecule force spectroscopy, molecular dynamics simulation","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-molecule AFM imaging plus simulations, single lab, two complementary methods","pmids":["32043141"],"is_preprint":false},{"year":2021,"finding":"Cryo-EM structure of PRC2 with JARID2 and AEBP2 bound to an H2AK119ub1-containing nucleosome revealed: JARID2 and AEBP2 each contact one ubiquitin moiety and the H2A-H2B surface; JARID2 stimulates PRC2 via interactions with EED and H2AK119-ubiquitin; AEBP2 has an additional scaffolding role. The presence of both cofactors partially overcomes the inhibitory effect of H3K4me3 and H3K36me3 on PRC2 activity.","method":"Cryo-electron microscopy, in vitro HMTase assay, cross-linking mass spectrometry","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution cryo-EM structure on modified nucleosome with biochemical functional validation, single lab","pmids":["33479123"],"is_preprint":false},{"year":2021,"finding":"AEBP2 regulates cooperative DNA looping by multiple PRC2 complexes; the association of AEBP2 with the C2 domain of SUZ12 blocks C2-DNA contacts, providing a mechanism by which AEBP2 modulates PRC2 genomic localization.","method":"Single-molecule force spectroscopy, coarse-grained/atomistic molecular dynamics simulations, free energy calculations","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-molecule experiments plus simulation, single lab","pmids":["34057467"],"is_preprint":false},{"year":2022,"finding":"In zebrafish embryos, H2Aub1 deposition by PRC1 (Rnf2) during pre-ZGA stages enables recruitment of Aebp2-containing PRC2 and subsequent H3K27me3 deposition during post-ZGA; inhibition of Rnf2 eliminates both Aebp2-PRC2 recruitment and H3K27me3, demonstrating that H2Aub1 is required upstream of Aebp2-PRC2 for gene silencing at ZGA.","method":"Rnf2 small-molecule inhibition in zebrafish embryos, ChIP-seq (H2Aub1, H3K27me3), RNA-seq, Aebp2-PRC2 co-localization","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic/chemical epistasis in vivo with ChIP-seq and transcriptomic readout, single lab","pmids":["34982026"],"is_preprint":false},{"year":2023,"finding":"H2A ubiquitination by PRC1 alters contacts between the H3 tail and DNA on nucleosomes, improving the methyltransferase activity of the PRC2-AEBP2-JARID2 complex; linker DNA is equally important as H2Aub for H3K27 methylation, and these effects synergize.","method":"In vitro HMTase assay with defined nucleosomes (±H2Aub, ±linker DNA), NMR/biophysical H3-tail dynamics measurements","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution with defined modified nucleosomes plus biophysical measurement of H3-tail dynamics, single lab","pmids":["36610636"],"is_preprint":false},{"year":2025,"finding":"The broadly expressed long isoform of AEBP2 (AEBP2L) inhibits PRC2, while the short isoform (AEBP2S) promotes PRC2 activity. AEBP2L inhibits PRC2 DNA binding, histone methyltransferase activity, and binding to target genes; AEBP2S promotes PRC2 DNA-binding and is essential for de novo repression during naïve-to-primed pluripotency transition. Cryo-EM and mutagenesis identified the negatively charged N-terminal region of AEBP2L as the inhibitory element, which is a recently evolved vertebrate feature.","method":"Cryo-EM, mutagenesis, in vitro HMTase assay, in vitro DNA binding assay, ChIP-seq, ESC differentiation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM plus mutagenesis plus biochemical assays plus in vivo ChIP-seq readout, single lab but multiple orthogonal methods","pmids":["41168462"],"is_preprint":false},{"year":2025,"finding":"AEBP2 long isoform N-terminal DE-rich motif inhibits both EZH2 automethylation and H3K27 methylation; AEBP2 short isoform enhances PRC2 catalytic activity and H3K27me3 spreading; re-expression of AEBP2L (but not AEBP2S) in Mtf2/Jarid2/Aebp2 triple-knockout mESCs failed to restore H3K27me3 and caused defective differentiation.","method":"In vitro HMTase assay, triple-knockout mESC complementation, H3K27me3 ChIP, differentiation assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic complementation plus biochemical assay in single lab, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.11.09.687442"],"is_preprint":true},{"year":2025,"finding":"In EZH2-mutant DLBCL, AEBP2 functions within a PRC2.2 complex lacking JARID2, using its zinc-finger domains to sample intergenic chromatin and sustain H3K27me2 (not H3K27me3-mediated gene silencing). Loss of AEBP2 reduces intergenic H3K27me2 and sensitizes cells to PRC2 inhibitors.","method":"CRISPR knockout, ChIP-seq (H3K27me2, H3K27me3), co-immunoprecipitation, functional drug sensitivity assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — KO with ChIP-seq and drug sensitivity readout, single lab, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.10.14.682307"],"is_preprint":true}],"current_model":"AEBP2 is an accessory subunit of Polycomb Repressive Complex 2 (PRC2) that exists as two functionally opposing isoforms: the embryo-specific short isoform (AEBP2S) stimulates PRC2 methyltransferase activity, enhances DNA binding, and promotes H3K27me3 spreading and de novo gene repression, while the broadly expressed long isoform (AEBP2L) inhibits PRC2 DNA binding and HMTase activity via its negatively charged N-terminal region; structurally, AEBP2 contacts the RBBP4 subunit (mimicking an unmodified H3 tail), binds ubiquitin on H2AK119ub1 nucleosomes, competes with PHF19 for the SUZ12 C2 domain, disrupts PRC2 dimerization, regulates DNA looping, and uses its zinc-finger domains to target PRC2.2 to intergenic chromatin to maintain H3K27me2; AEBP2 is also subject to SCF-β-TrCP-mediated ubiquitin-proteasomal degradation, and its levels influence cisplatin sensitivity in cancer cells."},"narrative":{"mechanistic_narrative":"AEBP2 is a zinc-finger accessory subunit of Polycomb Repressive Complex 2 (PRC2) that modulates the deposition and genomic targeting of repressive H3K27 methylation [PMID:15225548, PMID:27317809, PMID:29628311]. First characterized as a zinc-finger DNA-binding transcriptional repressor acting at the aP2 promoter [PMID:10329662], AEBP2 was subsequently shown to enhance the histone methyltransferase activity of the EED-EZH2-SUZ12 core above its minimal baseline through a mechanism independent of and additive to H3K27me3-driven allosteric activation [PMID:15225548, PMID:29681498]. Together with JARID2, AEBP2 defines the PRC2.2 subcomplex, which is mutually exclusive and antagonistic to the PCL/PALI1-containing PRC2.1 assembly [PMID:29628311]. Structural studies place AEBP2 in contact with the RBBP4 subunit, where it mimics an unmodified H3 tail and progressively blocks H3K4 binding, and show that AEBP2 and JARID2 each engage a ubiquitin moiety and the H2A-H2B surface of H2AK119ub1 nucleosomes to stimulate methylation and partly override the inhibitory effect of active marks H3K4me3 and H3K36me3 [PMID:29348366, PMID:29499137, PMID:33479123]. This nucleosomal engagement is the structural basis of a positive feedback loop in which PRC1-deposited H2Aub recruits JARID2-AEBP2-PRC2 to establish H3K27me3 domains, a relationship demonstrated in vitro and through in vivo epistasis at zebrafish zygotic genome activation [PMID:24837194, PMID:34982026, PMID:36610636]. AEBP2 controls PRC2 genomic localization by binding the non-canonical SUZ12 C2 domain, where it competes with PHF19, disrupts the intrinsic PRC2 dimer, blocks C2-DNA contacts, and thereby regulates cooperative DNA looping and chromatin residence [PMID:29499137, PMID:29891558, PMID:31959557, PMID:32043141]. AEBP2 exists as two developmentally regulated isoforms with opposing effects on PRC2: the embryo-specific short isoform stimulates DNA binding and de novo repression, while the broadly expressed long isoform inhibits PRC2 DNA binding and methyltransferase activity through a recently evolved, negatively charged N-terminal region [PMID:41168462]. In vivo, Aebp2 is essential for embryogenesis and neural crest development, with knockouts co-occupying and regulating neural crest migration genes alongside PRC2 [PMID:21949878, PMID:27317809]. AEBP2 is itself a substrate of SCF-β-TrCP-mediated ubiquitin-proteasomal degradation, and its abundance influences cisplatin sensitivity in cancer cells [PMID:31864706].","teleology":[{"year":1999,"claim":"Established AEBP2 as a sequence-specific zinc-finger transcriptional repressor before any link to chromatin complexes was known, defining its DNA-binding and repressive activities.","evidence":"Reporter and Gal4-fusion repression assays with zinc-finger mutagenesis and recombinant DNA-binding assay at the aP2 promoter","pmids":["10329662"],"confidence":"High","gaps":["No connection to PRC2 or chromatin modification yet","Physiological target genes not defined"]},{"year":2004,"claim":"Placed AEBP2 as a stimulatory cofactor of the PRC2 methyltransferase, distinguishing the minimal active core (EZH2-EED-SUZ12) from the optimal complex.","evidence":"In vitro HMTase reconstitution with defined subunit combinations","pmids":["15225548"],"confidence":"High","gaps":["Mechanism of stimulation not resolved","Did not address genomic targeting"]},{"year":2009,"claim":"Connected AEBP2's DNA binding to PRC2 by showing a bipartite recognition motif, two developmental isoforms, and genomic co-occupancy with SUZ12, framing it as a candidate PRC2 targeting factor.","evidence":"DNA-binding assays, ChIP co-occupancy, isoform RT-PCR and Western blot","pmids":["19293275"],"confidence":"Medium","gaps":["Targeting function inferred from co-occupancy, not causal recruitment","Functional difference between isoforms not yet defined"]},{"year":2011,"claim":"Demonstrated an essential in vivo role, with Aebp2 required for embryogenesis and neural crest development through co-regulation of migration genes with PRC2.","evidence":"Targeted mouse knockout with phenotypic analysis, ChIP, and expression profiling","pmids":["21949878"],"confidence":"High","gaps":["Direct molecular mechanism linking AEBP2 loss to gene dysregulation unresolved","Isoform-specific contributions not separated"]},{"year":2012,"claim":"Provided the first structural placement of AEBP2 within PRC2, indicating a stabilizing and potentially allosteric position.","evidence":"Electron microscopy with cross-linking mass spectrometry and internal protein tagging","pmids":["23110252"],"confidence":"High","gaps":["Resolution insufficient for atomic contacts","Nucleosome-bound state not captured"]},{"year":2014,"claim":"Defined a PRC1-PRC2 feedback loop in which H2Aub recruits JARID2-AEBP2-PRC2 to promote H3K27me3, and confirmed AEBP2 associates exclusively with PRC2 while defining mutually exclusive subcomplex composition; an unexpected Trithorax phenotype emerged from Aebp2 loss.","evidence":"Biochemical binding and HMTase assays on H2Aub nucleosomes; quantitative proteomics, IF/ChIP localization, ChIP-seq, and mouse mutants","pmids":["24837194","27317809","25451679"],"confidence":"High","gaps":["Structural basis of ubiquitin reading not yet defined","Reconciling repressive cofactor role with Trithorax loss-of-function phenotype unresolved"]},{"year":2018,"claim":"Resolved the atomic architecture and competitive logic of AEBP2 within PRC2 — RBBP4 contact mimicking an unmodified H3 tail, competition with PHF19 for the SUZ12 C2 domain, definition of the PRC2.2 subcomplex, allosteric-independent stimulation, and a dominant contribution to chromatin residence.","evidence":"Cryo-EM and X-ray crystallography of holo-complexes, HMTase and nucleosome-binding assays, live-cell single-particle tracking with SUZ12 separation-of-function mutants","pmids":["29348366","29499137","29681498","29628311","29891558"],"confidence":"High","gaps":["Isoform-specific structural differences not addressed","Quantitative balance of PRC2.1 vs PRC2.2 at individual loci unresolved"]},{"year":2020,"claim":"Mechanistically linked AEBP2's SUZ12 C2-domain binding to control of PRC2 dimerization, DNA looping, and CpG-island engagement, explaining how it tunes genomic localization.","evidence":"X-ray crystallography, in vitro DNA binding, ChIP-seq in mESCs, and single-molecule AFM/force spectroscopy with molecular dynamics","pmids":["31959557","32043141"],"confidence":"High","gaps":["In vivo consequence of looping modulation at native loci not fully mapped","Interplay with isoform identity not tested"]},{"year":2021,"claim":"Captured AEBP2 bound to an H2AK119ub1 nucleosome, defining its ubiquitin and H2A-H2B contacts and a scaffolding role that, with JARID2, partly overrides inhibitory active marks; in vivo epistasis confirmed H2Aub1 acts upstream of Aebp2-PRC2.","evidence":"Cryo-EM and HMTase assays on modified nucleosomes; Rnf2 inhibition in zebrafish with ChIP-seq and RNA-seq; single-molecule force spectroscopy with simulation","pmids":["33479123","34982026","34057467"],"confidence":"High","gaps":["Relative contribution of AEBP2 vs JARID2 ubiquitin reading not separated","Mammalian ZGA generalization untested"]},{"year":2023,"claim":"Showed H2A ubiquitination remodels H3-tail/DNA contacts and synergizes with linker DNA to enhance PRC2-AEBP2-JARID2 catalysis, providing the biophysical basis for activation.","evidence":"In vitro HMTase assays with defined nucleosomes and NMR/biophysical H3-tail dynamics measurements","pmids":["36610636"],"confidence":"High","gaps":["Cellular relevance of linker-DNA contribution untested","Isoform dependence not examined"]},{"year":2025,"claim":"Resolved the long-standing isoform puzzle by demonstrating that the long isoform inhibits PRC2 via a recently evolved negatively charged N-terminal region while the short isoform stimulates DNA binding and de novo repression, and extended AEBP2 function to JARID2-independent PRC2.2 maintaining intergenic H3K27me2 in cancer.","evidence":"Cryo-EM, mutagenesis, HMTase and DNA-binding assays, ChIP-seq and ESC differentiation (peer-reviewed); triple-KO complementation and DLBCL CRISPR/ChIP-seq with drug sensitivity (preprints)","pmids":["41168462","bio_10.1101_2025.11.09.687442","bio_10.1101_2025.10.14.682307"],"confidence":"High","gaps":["JARID2-independent PRC2.2 mechanism reported only in preprints","Physiological switch governing isoform choice undefined"]},{"year":null,"claim":"How AEBP2 isoform selection is regulated developmentally and how the opposing isoforms are coordinated at specific loci to set H3K27me2 versus H3K27me3 boundaries remains open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Upstream control of isoform expression unknown","Locus-level rules distinguishing AEBP2L inhibition from AEBP2S stimulation undefined","Link between AEBP2 degradation by SCF-β-TrCP and chromatin output not mechanistically established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,8,21]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,7]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,11,21]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[9,10,17]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[9,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,5,13,17]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,7,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,6,21]}],"complexes":["PRC2","PRC2.2"],"partners":["SUZ12","RBBP4","JARID2","EZH2","EED","PHF19"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q6ZN18","full_name":"Zinc finger protein AEBP2","aliases":["Adipocyte enhancer-binding protein 2","AE-binding protein 2"],"length_aa":517,"mass_kda":54.5,"function":"Acts as an accessory subunit for the core Polycomb repressive complex 2 (PRC2), which mediates histone H3K27 (H3K27me3) trimethylation on chromatin leading to transcriptional repression of the affected target gene (PubMed:15225548, PubMed:29499137, PubMed:31959557). Plays a role in nucleosome localization of the PRC2 complex (PubMed:29499137)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q6ZN18/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/AEBP2","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/AEBP2","total_profiled":1310},"omim":[{"mim_id":"617934","title":"AE-BINDING PROTEIN 2; AEBP2","url":"https://www.omim.org/entry/617934"},{"mim_id":"617795","title":"ELONGIN BC- AND POLYCOMB REPRESSIVE COMPLEX 2-ASSOCIATED PROTEIN; EPOP","url":"https://www.omim.org/entry/617795"},{"mim_id":"611799","title":"LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN; LCORL","url":"https://www.omim.org/entry/611799"},{"mim_id":"607698","title":"LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR; LCOR","url":"https://www.omim.org/entry/607698"},{"mim_id":"606245","title":"SUZ12 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT; SUZ12","url":"https://www.omim.org/entry/606245"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/AEBP2"},"hgnc":{"alias_symbol":["MGC17922"],"prev_symbol":[]},"alphafold":{"accession":"Q6ZN18","domains":[{"cath_id":"3.30.160.60","chopping":"260-325","consensus_level":"high","plddt":85.9021,"start":260,"end":325},{"cath_id":"-","chopping":"426-502","consensus_level":"medium","plddt":80.3168,"start":426,"end":502}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6ZN18","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6ZN18-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6ZN18-F1-predicted_aligned_error_v6.png","plddt_mean":61.84},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=AEBP2","jax_strain_url":"https://www.jax.org/strain/search?query=AEBP2"},"sequence":{"accession":"Q6ZN18","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6ZN18.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6ZN18/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6ZN18"}},"corpus_meta":[{"pmid":"15225548","id":"PMC_15225548","title":"SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15225548","citation_count":652,"is_preprint":false},{"pmid":"24837194","id":"PMC_24837194","title":"Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression.","date":"2014","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24837194","citation_count":357,"is_preprint":false},{"pmid":"33479123","id":"PMC_33479123","title":"JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications.","date":"2021","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33479123","citation_count":197,"is_preprint":false},{"pmid":"23110252","id":"PMC_23110252","title":"Molecular architecture of human polycomb repressive complex 2.","date":"2012","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/23110252","citation_count":194,"is_preprint":false},{"pmid":"29058709","id":"PMC_29058709","title":"Molecular analysis of PRC2 recruitment to DNA in chromatin and its inhibition by RNA.","date":"2017","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29058709","citation_count":178,"is_preprint":false},{"pmid":"29348366","id":"PMC_29348366","title":"Structures of human PRC2 with its cofactors AEBP2 and JARID2.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29348366","citation_count":168,"is_preprint":false},{"pmid":"19293275","id":"PMC_19293275","title":"AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19293275","citation_count":150,"is_preprint":false},{"pmid":"29628311","id":"PMC_29628311","title":"A Family of Vertebrate-Specific Polycombs Encoded by the LCOR/LCORL Genes Balance PRC2 Subtype Activities.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29628311","citation_count":128,"is_preprint":false},{"pmid":"29499137","id":"PMC_29499137","title":"Unique Structural Platforms of Suz12 Dictate Distinct Classes of PRC2 for Chromatin Binding.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29499137","citation_count":121,"is_preprint":false},{"pmid":"29681498","id":"PMC_29681498","title":"Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29681498","citation_count":109,"is_preprint":false},{"pmid":"22190018","id":"PMC_22190018","title":"Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.","date":"2011","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22190018","citation_count":91,"is_preprint":false},{"pmid":"27317809","id":"PMC_27317809","title":"Functional analysis of AEBP2, a PRC2 Polycomb protein, reveals a Trithorax phenotype in embryonic development and in ESCs.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27317809","citation_count":86,"is_preprint":false},{"pmid":"24550272","id":"PMC_24550272","title":"Reciprocal interactions of human C10orf12 and C17orf96 with PRC2 revealed by BioTAP-XL cross-linking and affinity purification.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24550272","citation_count":80,"is_preprint":false},{"pmid":"31959557","id":"PMC_31959557","title":"A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31959557","citation_count":74,"is_preprint":false},{"pmid":"25271128","id":"PMC_25271128","title":"Role of PRC2-associated factors in stem cells and disease.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/25271128","citation_count":70,"is_preprint":false},{"pmid":"29891558","id":"PMC_29891558","title":"Live-cell imaging reveals the dynamics of PRC2 and recruitment to chromatin by SUZ12-associated subunits.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29891558","citation_count":70,"is_preprint":false},{"pmid":"23744963","id":"PMC_23744963","title":"Recruitment and biological consequences of histone modification of H3K27me3 and H3K9me3.","date":"2012","source":"ILAR journal","url":"https://pubmed.ncbi.nlm.nih.gov/23744963","citation_count":68,"is_preprint":false},{"pmid":"31095801","id":"PMC_31095801","title":"Polycomb repressive 2 complex-Molecular mechanisms of function.","date":"2019","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/31095801","citation_count":64,"is_preprint":false},{"pmid":"21949878","id":"PMC_21949878","title":"Aebp2 as an epigenetic regulator for neural crest cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21949878","citation_count":45,"is_preprint":false},{"pmid":"10329662","id":"PMC_10329662","title":"Cloning and characterization of a novel zinc finger transcriptional repressor. A direct role of the zinc finger motif in repression.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10329662","citation_count":45,"is_preprint":false},{"pmid":"11152631","id":"PMC_11152631","title":"Jing: a downstream target of slbo required for developmental control of border cell migration.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11152631","citation_count":39,"is_preprint":false},{"pmid":"35997369","id":"PMC_35997369","title":"The Role of Polycomb Proteins in Cell Lineage Commitment and Embryonic Development.","date":"2022","source":"Epigenomes","url":"https://pubmed.ncbi.nlm.nih.gov/35997369","citation_count":34,"is_preprint":false},{"pmid":"34982026","id":"PMC_34982026","title":"Establishment of developmental gene silencing by ordered polycomb complex recruitment in early zebrafish embryos.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34982026","citation_count":32,"is_preprint":false},{"pmid":"34057467","id":"PMC_34057467","title":"Cooperative DNA looping by PRC2 complexes.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34057467","citation_count":25,"is_preprint":false},{"pmid":"34923368","id":"PMC_34923368","title":"Genome-wide gene-air pollution interaction analysis of lung function in 300,000 individuals.","date":"2021","source":"Environment international","url":"https://pubmed.ncbi.nlm.nih.gov/34923368","citation_count":25,"is_preprint":false},{"pmid":"31864706","id":"PMC_31864706","title":"β-TRCP-mediated AEBP2 ubiquitination and destruction controls cisplatin resistance in ovarian cancer.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31864706","citation_count":24,"is_preprint":false},{"pmid":"37105392","id":"PMC_37105392","title":"Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37105392","citation_count":18,"is_preprint":false},{"pmid":"12015288","id":"PMC_12015288","title":"The jing Zn-finger transcription factor is a mediator of cellular differentiation in the Drosophila CNS midline and trachea.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12015288","citation_count":18,"is_preprint":false},{"pmid":"25451679","id":"PMC_25451679","title":"AEBP2 as a transcriptional activator and its role in cell migration.","date":"2014","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/25451679","citation_count":17,"is_preprint":false},{"pmid":"33558851","id":"PMC_33558851","title":"SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection.","date":"2021","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/33558851","citation_count":17,"is_preprint":false},{"pmid":"36610636","id":"PMC_36610636","title":"H2A Ubiquitination Alters H3-tail Dynamics on Linker-DNA to Enhance H3K27 Methylation.","date":"2023","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36610636","citation_count":15,"is_preprint":false},{"pmid":"32043141","id":"PMC_32043141","title":"Bending and looping of long DNA by Polycomb repressive complex 2 revealed by AFM imaging in liquid.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32043141","citation_count":15,"is_preprint":false},{"pmid":"25148369","id":"PMC_25148369","title":"Profiling of embryonic stem cell differentiation.","date":"2014","source":"The review of diabetic studies : RDS","url":"https://pubmed.ncbi.nlm.nih.gov/25148369","citation_count":14,"is_preprint":false},{"pmid":"27022003","id":"PMC_27022003","title":"The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes.","date":"2016","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/27022003","citation_count":11,"is_preprint":false},{"pmid":"34169730","id":"PMC_34169730","title":"Three genes associated with anterior and posterior cruciate ligament injury : a genome-wide association analysis.","date":"2021","source":"Bone & joint open","url":"https://pubmed.ncbi.nlm.nih.gov/34169730","citation_count":11,"is_preprint":false},{"pmid":"34352938","id":"PMC_34352938","title":"AC092127.1-miR-451a-AE binding protein 2 Signaling Facilitates Malignant Properties of Breast Cancer.","date":"2021","source":"Journal of breast cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34352938","citation_count":5,"is_preprint":false},{"pmid":"38678819","id":"PMC_38678819","title":"A preliminary study unveils CISD2 as a ferroptosis-related therapeutic target for recurrent spontaneous abortion through immunological analysis and two-sample mendelian randomization.","date":"2024","source":"Journal of reproductive immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38678819","citation_count":4,"is_preprint":false},{"pmid":"39042632","id":"PMC_39042632","title":"Exploring the role of ferroptosis-related genes as biomarkers in acute kidney injury.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39042632","citation_count":3,"is_preprint":false},{"pmid":"39572917","id":"PMC_39572917","title":"Development and Validation of a Diagnostic Model for AKI Based on the Analysis of Ferroptosis-related Genes.","date":"2025","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39572917","citation_count":1,"is_preprint":false},{"pmid":"41168462","id":"PMC_41168462","title":"Auto-inhibition of PRC2 by the broadly expressed long isoform of AEBP2.","date":"2025","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/41168462","citation_count":0,"is_preprint":false},{"pmid":"25915901","id":"PMC_25915901","title":"Retrotransposon-derived promoter of Mammalian Aebp2.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25915901","citation_count":0,"is_preprint":false},{"pmid":"41009685","id":"PMC_41009685","title":"Integrated miRNA-mRNA Analyses of Triple-Negative Breast Cancer in Black and White Patients with or Without Obesity.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41009685","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.09.687442","title":"Distinct regulation of AEBP2 isoforms on PRC2 activity","date":"2025-11-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.09.687442","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.14.682307","title":"AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma","date":"2025-10-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.14.682307","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.23.619919","title":"Circular RNA AEBP2: A novel regulator in dendritic cell development","date":"2024-10-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.23.619919","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21749,"output_tokens":6074,"usd":0.078178,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14576,"output_tokens":4440,"usd":0.09194,"stage2_stop_reason":"end_turn"},"total_usd":0.170118,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"AEBP2 is a zinc finger transcriptional repressor that binds to the AE-1 regulatory sequence in the aP2 gene promoter; the zinc finger motif plays a direct role in transcriptional repression (but not DNA binding), as mutation of a conserved histidine and flanking serine in the middle zinc finger abolished repression without affecting nuclear localization or DNA binding.\",\n      \"method\": \"Co-transfection reporter assay, Gal4-fusion repression assay, site-directed mutagenesis of zinc finger, recombinant protein DNA-binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro DNA binding assay plus mutagenesis plus functional reporter assay, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"10329662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"AEBP2 is required for optimal (but not minimal) histone methyltransferase activity of the EED-EZH2-SUZ12 PRC2 complex; the minimum active complex requires EZH2, EED, and SUZ12, while AEBP2 enhances enzymatic activity above this baseline.\",\n      \"method\": \"In vitro histone methyltransferase (HMTase) reconstitution assay with defined subunit combinations\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution with defined subunit combinations, replicated in multiple subsequent studies\",\n      \"pmids\": [\"15225548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"AEBP2 is an evolutionarily conserved zinc finger protein that binds DNA via a bipartite motif (CTT(N)15-23cagGCC), exists as two developmental-stage-specific isoforms (adult 51 kDa and embryo 32 kDa), and co-occupies genomic loci with SUZ12, functioning as a potential targeting factor for mammalian PRC2.\",\n      \"method\": \"DNA-binding assays, ChIP, promoter-GFP reporter, RT-PCR isoform characterization, Western blot\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and DNA binding assay in single lab, two orthogonal methods (DNA binding + ChIP co-occupancy)\",\n      \"pmids\": [\"19293275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In developing mouse embryos, Aebp2 is expressed mainly in neural crest-derived cells; homozygous Aebp2 knockout is embryonic lethal, and heterozygotes display neural crest defects (enlarged colon, hypopigmentation). ChIP analyses showed that AEBP2 and PRC2 co-occupy promoters of genes involved in neural crest cell migration and development, and expression of these genes is altered in Aebp2 heterozygotes.\",\n      \"method\": \"Targeted mouse knockout, phenotypic analysis, ChIP, expression analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with defined phenotypic readout plus ChIP validation, single lab\",\n      \"pmids\": [\"21949878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The first 3D electron microscopy structure of human PRC2 bound to cofactor AEBP2 revealed that AEBP2 stabilizes the complex and occupies a position suggesting an allosteric role in regulating gene silencing; cross-linking mass spectrometry and internal protein tagging localized all PRC2 subunits and mapped AEBP2 interactions within the assembly.\",\n      \"method\": \"Electron microscopy, cross-linking mass spectrometry, internal protein tagging\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure with cross-linking MS validation, single lab but multiple orthogonal structural methods\",\n      \"pmids\": [\"23110252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Monoubiquitination of histone H2A by PRC1 (H2Aub) creates a binding site for Jarid2-Aebp2-containing PRC2, promoting H3K27 trimethylation on H2Aub nucleosomes; Jarid2, Aebp2, and H2Aub constitute a positive feedback loop establishing H3K27me3 chromatin domains.\",\n      \"method\": \"Biochemical binding assays, in vitro HMTase assay with H2Aub nucleosomes, mass spectrometry\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted biochemical assay with defined modified nucleosomes plus mechanistic follow-up, replicated by subsequent structural studies\",\n      \"pmids\": [\"24837194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"AEBP2 localizes specifically to PRC2 target loci including the inactive X chromosome; proteomic analysis confirmed AEBP2 associates exclusively with PRC2 complexes. In Aebp2 mutant ESCs, elevated H3K27 methylation at target loci was observed and atypical hybrid PRC2 subcomplexes assembled, suggesting AEBP2 normally defines mutually exclusive PRC2 subcomplex composition. Unexpectedly, homozygous Aebp2 mutant embryos display a Trithorax (anti-Polycomb) phenotype.\",\n      \"method\": \"Targeted mouse mutation, immunofluorescence/ChIP localization, quantitative proteomics (mass spectrometry), ChIP-seq H3K27me3 profiling\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal proteomic validation, ChIP-seq, and in vivo loss-of-function with multiple orthogonal methods in single lab\",\n      \"pmids\": [\"27317809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The somatic (long, 52 kDa) isoform of AEBP2 acts as a transcriptional activator for Jarid2, Aebp2, and Snai2 target genes, whereas the embryonic (short, 32 kDa) isoform acts as a transcriptional repressor for Snai2; the somatic form also enhances cell migration. AEBP2 binds its own promoter and the promoters of Jarid2 and Snai2 as shown by ChIP.\",\n      \"method\": \"Reporter/transfection assays, ChIP, cell migration assay, RT-PCR isoform characterization\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional reporter assays plus cell migration readout, single lab\",\n      \"pmids\": [\"25451679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The AEBP2 subunit of PRC2 regulates preferential binding of PRC2 to methylated DNA (CpG-rich sequences); inclusion of AEBP2 in the PRC2 complex mediates this specificity for methylated DNA.\",\n      \"method\": \"In vitro binding assays with reconstituted PRC2 ± AEBP2, methylated vs. unmethylated DNA substrates\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted biochemical binding assay with defined components, single lab\",\n      \"pmids\": [\"29058709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cryo-EM structures of human PRC2 with JARID2 and AEBP2 in basal and active states showed that AEBP2 interacts with the RBAP48 (RBBP4) subunit, mimicking an unmodified H3 tail. SUZ12 interacts with all other subunits; together these interactions define the complete architecture of the complex.\",\n      \"method\": \"Cryo-electron microscopy, cross-linking mass spectrometry\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution cryo-EM structures in multiple functional states, corroborated by cross-linking MS\",\n      \"pmids\": [\"29348366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AEBP2 and PHF19 compete for binding to the non-canonical C2 domain of SUZ12; AEBP2 and JARID2 together enable nucleosome binding by the PRC2 complex. Crystal structures show that SUZ12 contains two structural platforms defining distinct PRC2 holo-complex classes. AEBP2 progressively blocks histone H3K4 binding to RBBP4 together with SUZ12.\",\n      \"method\": \"X-ray crystallography (crystal structures of heterotetrameric complexes), in vitro nucleosome binding assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures with biochemical validation, single lab\",\n      \"pmids\": [\"29499137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AEBP2 stimulates both PRC2-EZH1 and PRC2-EZH2 methyltransferase activity through a mechanism that is independent of and additive to allosteric activation (by H3K27me3), distinguishing AEBP2-mediated stimulation from the allosteric pathway.\",\n      \"method\": \"In vitro HMTase assay with defined subunit combinations, allosteric activator competition assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with multiple subunit combinations identifying independent activation mechanisms, single lab\",\n      \"pmids\": [\"29681498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AEBP2 and PCL homolog proteins make a major contribution to PRC2 chromatin binding in living human cells; SUZ12 separation-of-function mutants that cannot bind accessory proteins (including AEBP2) greatly reduce chromatin residence time of PRC2, as measured by single-particle tracking.\",\n      \"method\": \"CRISPR genome editing (HaloTag knock-in), single-particle tracking in live cells, SUZ12 separation-of-function mutants\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous tagging plus live-cell single-particle tracking plus separation-of-function mutants, single lab\",\n      \"pmids\": [\"29891558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AEBP2 and JARID2 define the PRC2.2 subcomplex, which is mutually exclusive and antagonistic relative to the PRC2.1 subcomplex (containing PALI1/PCL proteins); the balance of PRC2.1 and PRC2.2 activities is required for appropriate regulation of polycomb target genes during differentiation.\",\n      \"method\": \"In vitro HMTase assay, co-immunoprecipitation, mouse genetic knockout, differentiation assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (biochemical, genetic, cellular), replicated by subsequent studies defining PRC2.1/PRC2.2 distinction\",\n      \"pmids\": [\"29628311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"AEBP2 contains a non-canonical phosphodegron and is targeted for ubiquitylation and proteasomal degradation by the SCF-β-TrCP E3 ubiquitin ligase complex; failure to degrade AEBP2 confers cisplatin resistance in ovarian cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, AEBP2 knockout cell lines, cisplatin sensitivity assay, phosphodegron mutagenesis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — co-IP and functional KO phenotype, single lab, moderate mechanistic follow-up\",\n      \"pmids\": [\"31864706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AEBP2 binding to the C2 domain of SUZ12 disrupts the intrinsic PRC2 dimer (formed by domain swapping involving RBBP4 and the SUZ12 C2 domain), whereas MTF2/PHF19 stabilize the dimer; PRC2 dimerization enhances CpG island DNA binding, and loss of dimerization impairs H3K27me3 at developmental gene loci.\",\n      \"method\": \"X-ray crystallography, in vitro DNA binding assay, ChIP-seq in mouse ESCs\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures plus biochemical DNA binding plus in vivo ChIP validation, single lab\",\n      \"pmids\": [\"31959557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PRC2 (five-subunit complex including AEBP2) bends DNA approximately 3-fold locally and mediates DNA looping via multiple PRC2 molecules binding cooperatively; AEBP2 regulates loop formation, in part by associating with the C2 domain of SUZ12 and blocking its DNA contact.\",\n      \"method\": \"Atomic force microscopy (single-molecule, in liquid), single-molecule force spectroscopy, molecular dynamics simulation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-molecule AFM imaging plus simulations, single lab, two complementary methods\",\n      \"pmids\": [\"32043141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cryo-EM structure of PRC2 with JARID2 and AEBP2 bound to an H2AK119ub1-containing nucleosome revealed: JARID2 and AEBP2 each contact one ubiquitin moiety and the H2A-H2B surface; JARID2 stimulates PRC2 via interactions with EED and H2AK119-ubiquitin; AEBP2 has an additional scaffolding role. The presence of both cofactors partially overcomes the inhibitory effect of H3K4me3 and H3K36me3 on PRC2 activity.\",\n      \"method\": \"Cryo-electron microscopy, in vitro HMTase assay, cross-linking mass spectrometry\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution cryo-EM structure on modified nucleosome with biochemical functional validation, single lab\",\n      \"pmids\": [\"33479123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AEBP2 regulates cooperative DNA looping by multiple PRC2 complexes; the association of AEBP2 with the C2 domain of SUZ12 blocks C2-DNA contacts, providing a mechanism by which AEBP2 modulates PRC2 genomic localization.\",\n      \"method\": \"Single-molecule force spectroscopy, coarse-grained/atomistic molecular dynamics simulations, free energy calculations\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-molecule experiments plus simulation, single lab\",\n      \"pmids\": [\"34057467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In zebrafish embryos, H2Aub1 deposition by PRC1 (Rnf2) during pre-ZGA stages enables recruitment of Aebp2-containing PRC2 and subsequent H3K27me3 deposition during post-ZGA; inhibition of Rnf2 eliminates both Aebp2-PRC2 recruitment and H3K27me3, demonstrating that H2Aub1 is required upstream of Aebp2-PRC2 for gene silencing at ZGA.\",\n      \"method\": \"Rnf2 small-molecule inhibition in zebrafish embryos, ChIP-seq (H2Aub1, H3K27me3), RNA-seq, Aebp2-PRC2 co-localization\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic/chemical epistasis in vivo with ChIP-seq and transcriptomic readout, single lab\",\n      \"pmids\": [\"34982026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"H2A ubiquitination by PRC1 alters contacts between the H3 tail and DNA on nucleosomes, improving the methyltransferase activity of the PRC2-AEBP2-JARID2 complex; linker DNA is equally important as H2Aub for H3K27 methylation, and these effects synergize.\",\n      \"method\": \"In vitro HMTase assay with defined nucleosomes (±H2Aub, ±linker DNA), NMR/biophysical H3-tail dynamics measurements\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution with defined modified nucleosomes plus biophysical measurement of H3-tail dynamics, single lab\",\n      \"pmids\": [\"36610636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The broadly expressed long isoform of AEBP2 (AEBP2L) inhibits PRC2, while the short isoform (AEBP2S) promotes PRC2 activity. AEBP2L inhibits PRC2 DNA binding, histone methyltransferase activity, and binding to target genes; AEBP2S promotes PRC2 DNA-binding and is essential for de novo repression during naïve-to-primed pluripotency transition. Cryo-EM and mutagenesis identified the negatively charged N-terminal region of AEBP2L as the inhibitory element, which is a recently evolved vertebrate feature.\",\n      \"method\": \"Cryo-EM, mutagenesis, in vitro HMTase assay, in vitro DNA binding assay, ChIP-seq, ESC differentiation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM plus mutagenesis plus biochemical assays plus in vivo ChIP-seq readout, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"41168462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AEBP2 long isoform N-terminal DE-rich motif inhibits both EZH2 automethylation and H3K27 methylation; AEBP2 short isoform enhances PRC2 catalytic activity and H3K27me3 spreading; re-expression of AEBP2L (but not AEBP2S) in Mtf2/Jarid2/Aebp2 triple-knockout mESCs failed to restore H3K27me3 and caused defective differentiation.\",\n      \"method\": \"In vitro HMTase assay, triple-knockout mESC complementation, H3K27me3 ChIP, differentiation assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic complementation plus biochemical assay in single lab, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.11.09.687442\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In EZH2-mutant DLBCL, AEBP2 functions within a PRC2.2 complex lacking JARID2, using its zinc-finger domains to sample intergenic chromatin and sustain H3K27me2 (not H3K27me3-mediated gene silencing). Loss of AEBP2 reduces intergenic H3K27me2 and sensitizes cells to PRC2 inhibitors.\",\n      \"method\": \"CRISPR knockout, ChIP-seq (H3K27me2, H3K27me3), co-immunoprecipitation, functional drug sensitivity assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — KO with ChIP-seq and drug sensitivity readout, single lab, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.10.14.682307\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"AEBP2 is an accessory subunit of Polycomb Repressive Complex 2 (PRC2) that exists as two functionally opposing isoforms: the embryo-specific short isoform (AEBP2S) stimulates PRC2 methyltransferase activity, enhances DNA binding, and promotes H3K27me3 spreading and de novo gene repression, while the broadly expressed long isoform (AEBP2L) inhibits PRC2 DNA binding and HMTase activity via its negatively charged N-terminal region; structurally, AEBP2 contacts the RBBP4 subunit (mimicking an unmodified H3 tail), binds ubiquitin on H2AK119ub1 nucleosomes, competes with PHF19 for the SUZ12 C2 domain, disrupts PRC2 dimerization, regulates DNA looping, and uses its zinc-finger domains to target PRC2.2 to intergenic chromatin to maintain H3K27me2; AEBP2 is also subject to SCF-β-TrCP-mediated ubiquitin-proteasomal degradation, and its levels influence cisplatin sensitivity in cancer cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"AEBP2 is a zinc-finger accessory subunit of Polycomb Repressive Complex 2 (PRC2) that modulates the deposition and genomic targeting of repressive H3K27 methylation [#1, #6, #13]. First characterized as a zinc-finger DNA-binding transcriptional repressor acting at the aP2 promoter [#0], AEBP2 was subsequently shown to enhance the histone methyltransferase activity of the EED-EZH2-SUZ12 core above its minimal baseline through a mechanism independent of and additive to H3K27me3-driven allosteric activation [#1, #11]. Together with JARID2, AEBP2 defines the PRC2.2 subcomplex, which is mutually exclusive and antagonistic to the PCL/PALI1-containing PRC2.1 assembly [#13]. Structural studies place AEBP2 in contact with the RBBP4 subunit, where it mimics an unmodified H3 tail and progressively blocks H3K4 binding, and show that AEBP2 and JARID2 each engage a ubiquitin moiety and the H2A-H2B surface of H2AK119ub1 nucleosomes to stimulate methylation and partly override the inhibitory effect of active marks H3K4me3 and H3K36me3 [#9, #10, #17]. This nucleosomal engagement is the structural basis of a positive feedback loop in which PRC1-deposited H2Aub recruits JARID2-AEBP2-PRC2 to establish H3K27me3 domains, a relationship demonstrated in vitro and through in vivo epistasis at zebrafish zygotic genome activation [#5, #19, #20]. AEBP2 controls PRC2 genomic localization by binding the non-canonical SUZ12 C2 domain, where it competes with PHF19, disrupts the intrinsic PRC2 dimer, blocks C2-DNA contacts, and thereby regulates cooperative DNA looping and chromatin residence [#10, #12, #15, #16]. AEBP2 exists as two developmentally regulated isoforms with opposing effects on PRC2: the embryo-specific short isoform stimulates DNA binding and de novo repression, while the broadly expressed long isoform inhibits PRC2 DNA binding and methyltransferase activity through a recently evolved, negatively charged N-terminal region [#21]. In vivo, Aebp2 is essential for embryogenesis and neural crest development, with knockouts co-occupying and regulating neural crest migration genes alongside PRC2 [#3, #6]. AEBP2 is itself a substrate of SCF-β-TrCP-mediated ubiquitin-proteasomal degradation, and its abundance influences cisplatin sensitivity in cancer cells [#14].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established AEBP2 as a sequence-specific zinc-finger transcriptional repressor before any link to chromatin complexes was known, defining its DNA-binding and repressive activities.\",\n      \"evidence\": \"Reporter and Gal4-fusion repression assays with zinc-finger mutagenesis and recombinant DNA-binding assay at the aP2 promoter\",\n      \"pmids\": [\"10329662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No connection to PRC2 or chromatin modification yet\", \"Physiological target genes not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed AEBP2 as a stimulatory cofactor of the PRC2 methyltransferase, distinguishing the minimal active core (EZH2-EED-SUZ12) from the optimal complex.\",\n      \"evidence\": \"In vitro HMTase reconstitution with defined subunit combinations\",\n      \"pmids\": [\"15225548\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of stimulation not resolved\", \"Did not address genomic targeting\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected AEBP2's DNA binding to PRC2 by showing a bipartite recognition motif, two developmental isoforms, and genomic co-occupancy with SUZ12, framing it as a candidate PRC2 targeting factor.\",\n      \"evidence\": \"DNA-binding assays, ChIP co-occupancy, isoform RT-PCR and Western blot\",\n      \"pmids\": [\"19293275\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Targeting function inferred from co-occupancy, not causal recruitment\", \"Functional difference between isoforms not yet defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated an essential in vivo role, with Aebp2 required for embryogenesis and neural crest development through co-regulation of migration genes with PRC2.\",\n      \"evidence\": \"Targeted mouse knockout with phenotypic analysis, ChIP, and expression profiling\",\n      \"pmids\": [\"21949878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular mechanism linking AEBP2 loss to gene dysregulation unresolved\", \"Isoform-specific contributions not separated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided the first structural placement of AEBP2 within PRC2, indicating a stabilizing and potentially allosteric position.\",\n      \"evidence\": \"Electron microscopy with cross-linking mass spectrometry and internal protein tagging\",\n      \"pmids\": [\"23110252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Resolution insufficient for atomic contacts\", \"Nucleosome-bound state not captured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined a PRC1-PRC2 feedback loop in which H2Aub recruits JARID2-AEBP2-PRC2 to promote H3K27me3, and confirmed AEBP2 associates exclusively with PRC2 while defining mutually exclusive subcomplex composition; an unexpected Trithorax phenotype emerged from Aebp2 loss.\",\n      \"evidence\": \"Biochemical binding and HMTase assays on H2Aub nucleosomes; quantitative proteomics, IF/ChIP localization, ChIP-seq, and mouse mutants\",\n      \"pmids\": [\"24837194\", \"27317809\", \"25451679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of ubiquitin reading not yet defined\", \"Reconciling repressive cofactor role with Trithorax loss-of-function phenotype unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the atomic architecture and competitive logic of AEBP2 within PRC2 — RBBP4 contact mimicking an unmodified H3 tail, competition with PHF19 for the SUZ12 C2 domain, definition of the PRC2.2 subcomplex, allosteric-independent stimulation, and a dominant contribution to chromatin residence.\",\n      \"evidence\": \"Cryo-EM and X-ray crystallography of holo-complexes, HMTase and nucleosome-binding assays, live-cell single-particle tracking with SUZ12 separation-of-function mutants\",\n      \"pmids\": [\"29348366\", \"29499137\", \"29681498\", \"29628311\", \"29891558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Isoform-specific structural differences not addressed\", \"Quantitative balance of PRC2.1 vs PRC2.2 at individual loci unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mechanistically linked AEBP2's SUZ12 C2-domain binding to control of PRC2 dimerization, DNA looping, and CpG-island engagement, explaining how it tunes genomic localization.\",\n      \"evidence\": \"X-ray crystallography, in vitro DNA binding, ChIP-seq in mESCs, and single-molecule AFM/force spectroscopy with molecular dynamics\",\n      \"pmids\": [\"31959557\", \"32043141\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo consequence of looping modulation at native loci not fully mapped\", \"Interplay with isoform identity not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Captured AEBP2 bound to an H2AK119ub1 nucleosome, defining its ubiquitin and H2A-H2B contacts and a scaffolding role that, with JARID2, partly overrides inhibitory active marks; in vivo epistasis confirmed H2Aub1 acts upstream of Aebp2-PRC2.\",\n      \"evidence\": \"Cryo-EM and HMTase assays on modified nucleosomes; Rnf2 inhibition in zebrafish with ChIP-seq and RNA-seq; single-molecule force spectroscopy with simulation\",\n      \"pmids\": [\"33479123\", \"34982026\", \"34057467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of AEBP2 vs JARID2 ubiquitin reading not separated\", \"Mammalian ZGA generalization untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed H2A ubiquitination remodels H3-tail/DNA contacts and synergizes with linker DNA to enhance PRC2-AEBP2-JARID2 catalysis, providing the biophysical basis for activation.\",\n      \"evidence\": \"In vitro HMTase assays with defined nucleosomes and NMR/biophysical H3-tail dynamics measurements\",\n      \"pmids\": [\"36610636\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular relevance of linker-DNA contribution untested\", \"Isoform dependence not examined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved the long-standing isoform puzzle by demonstrating that the long isoform inhibits PRC2 via a recently evolved negatively charged N-terminal region while the short isoform stimulates DNA binding and de novo repression, and extended AEBP2 function to JARID2-independent PRC2.2 maintaining intergenic H3K27me2 in cancer.\",\n      \"evidence\": \"Cryo-EM, mutagenesis, HMTase and DNA-binding assays, ChIP-seq and ESC differentiation (peer-reviewed); triple-KO complementation and DLBCL CRISPR/ChIP-seq with drug sensitivity (preprints)\",\n      \"pmids\": [\"41168462\", \"bio_10.1101_2025.11.09.687442\", \"bio_10.1101_2025.10.14.682307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"JARID2-independent PRC2.2 mechanism reported only in preprints\", \"Physiological switch governing isoform choice undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How AEBP2 isoform selection is regulated developmentally and how the opposing isoforms are coordinated at specific loci to set H3K27me2 versus H3K27me3 boundaries remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream control of isoform expression unknown\", \"Locus-level rules distinguishing AEBP2L inhibition from AEBP2S stimulation undefined\", \"Link between AEBP2 degradation by SCF-β-TrCP and chromatin output not mechanistically established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 8, 21]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 11, 21]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [9, 10, 17]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [9, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 5, 13, 17]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 7, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 6, 21]}\n    ],\n    \"complexes\": [\"PRC2\", \"PRC2.2\"],\n    \"partners\": [\"SUZ12\", \"RBBP4\", \"JARID2\", \"EZH2\", \"EED\", \"PHF19\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}